This new product lineup represents a key breakthrough for the automotive brand in international markets BAODING, China, Sept. 17, 2020 /PRNewswire/ — GWM (601633.SS/02333.HK), a world-renowned SUV and pickup manufacturer, has announced the global rollout plan of its P Series Pickup. This series, developed on the carmaker’s new P71 platform, a production system fully compliant with a series of regulations for safety, emissions of global standards and designed for global markets in line…
Sale based on enterprise value of $8.4 billion (EUR 7.15B), reflecting a post-MOU $350M (€300M) price reduction, offset by positive foreign currency impact Net proceeds to Bombardier expected to be ~$4.0B at closing Closing now expected in the first quarter of 2021, subject to customary closing conditions and remaining regulatory approvals All amounts in this press release are in U.S. dollars unless otherwise indicated. Amounts in EUR in this press…
تمكن Opaganib من تثبيط التكاثر الفيروسي لفيروس سارس-كوف-2 تمامًا، كما تم قياسه بعد ثلاثة أيام من الحضانة في نموذج مختبري لأنسجة الشعب الهوائية البشرية، مقارنة بشكل إيجابي مع عقار remdesivir، وهو عنصر التحكم الإيجابي في الدراسة — يحتل Opaganib موقعًا فريدًا باعتباره علاجًا محتملاً لفيروس كوفيد-19 يتم تناوله عن طريق الفم يجمع بين آليات عمل فعالة مضادة للفيروسات ومضادة للالتهابات، ويستهدف مكون الخلية المضيفة ويقلل من احتمالية المقاومة — تُجرى…
تمكن Opaganib من تثبيط التكاثر الفيروسي لفيروس سارس-كوف-2 تمامًا، كما تم قياسه بعد ثلاثة أيام من الحضانة في نموذج مختبري لأنسجة الشعب الهوائية البشرية، مقارنة بشكل إيجابي مع عقار remdesivir، وهو عنصر التحكم الإيجابي في الدراسة — يحتل Opaganib موقعًا فريدًا باعتباره علاجًا محتملاً لفيروس كوفيد-19 يتم تناوله عن طريق الفم يجمع بين آليات عمل فعالة مضادة للفيروسات ومضادة للالتهابات، ويستهدف مكون الخلية المضيفة ويقلل من احتمالية المقاومة — تُجرى…
Opaganib blocks SARS-Cov-2 virus replication Opaganib blocks SARS-Cov-2 virus replication Opaganib completely inhibited SARS-CoV-2 viral replication as measured after three days incubation in an in vitro model of human bronchial tissue, comparing favorably with remdesivir, the positive control in the study — Opaganib is uniquely positioned as an orally-administered potential COVID-19 treatment combining potent antiviral and anti-inflammatory mechanisms of action, targeting a host cell component and minimizing likelihood of resistance…
DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution Licensing Agreement to add MeMed BV™, Immune System Based Protein Signature Test for Distinguishing between Bacterial vs. Viral Infections, to the broad DiaSorin LIAISONÒ test menu, available on LIAISONÒ analyzers SALUGGIA, Italy and HAIFA, Israel, September 8, 2020 – DiaSorin (FTSE MIB: DIA) and MeMed have announced today the creation of a strategic partnership…
LONDON, UK, Sept. 02, 2020 (GLOBE NEWSWIRE) — [INVNT GROUP], THE GLOBAL BRANDSTORY PROJECT™ has recruited a new Managing Director for EMEA in renowned and highly regarded industry leader, Claudia Stephenson, a move that has been fuelled by increased demand for the GROUP’s multi-disciplinary offering amid the pandemic. An excellent communicator with long-standing client relationships across sectors including tech, gaming, HR and healthcare, Stephenson joins from Freeman and brings 20…
In Sphera’s recent survey, industry leaders express need for technology solutions that help achieve operational resilience CHICAGO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Sphera, the leading global provider of Integrated Risk Management (IRM) software, data and consulting services, has released the latest results of its annual Process Safety Management/Operational Risk Management survey. The 2020 survey marks the industry’s fifth consecutive report on the trends of Process Safety and Operational Risk Management.…
